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Abstract Physical activity can affect ‘need’ for healthcare
both by reducing the incidence rate of some diseases and
by increasing longevity (increasing the time lived at older
ages when disease incidence is higher). However, it is
common to consider only the first effect, which may
overestimate any reduction in need for healthcare. We
developed a hybrid micro-simulation lifetable model,
which made allowance for both changes in longevity and
risk of disease incidence, to estimate the effects of
increases in physical activity (all adults meeting guideli-
nes) on measures of healthcare need for diseases for which
physical activity is protective. These were compared with
estimates made using comparative risk assessment (CRA)
methods, which assumed that longevity was fixed. Using
the lifetable model, life expectancy increased by 95 days
(95% uncertainty intervals: 68–126 days). Estimates of the
healthcare need tended to decrease, but the magnitude of
the decreases were noticeably smaller than those estimated
using CRA methods (e.g. dementia: change in person-
years, -0.6%, 95% uncertainty interval -3.7% to ?1.6%;
change in incident cases, -0.4%, -3.6% to ?1.9%; change
in person-years (CRA methods), -4.0%, -7.4% to
-1.6%). The pattern of results persisted under different
scenarios and sensitivity analyses. For most diseases for
which physical activity is protective, increases in physical
activity are associated with decreases in indices of
healthcare need. However, disease onset may be delayed or
time lived with disease may increase, such that the
decreases in need may be relatively small and less than is
sometimes expected.
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Introduction
People who undertake regular physical activity tend to
experience better health and live longer [1–3]. Many
countries therefore aim to promote physical activity to
improve population health [4–6]. Some go further and
assume that increases in it will also reduce ‘need’ for health
and social care [4, 7–9]. The implicit logic appears to be
that improving the population distribution of a risk factor
such as physical activity will reduce the incidence rate of
disease, thereby resulting in fewer incident cases and fewer
people living with disease, thereby reducing need for
healthcare.
Effect of physical activity on disease
However, increases in physical activity may affect the
number of people living with disease by several pathways,
not all of which will act to reduce the number of people
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living with disease (see Fig. 1). First a reduction in relative
risk, arising from an increase in physical activity, will lead
to a reduction in the incidence rate of disease. All other
things being equal, this will result in fewer incident cases
of diseases and consequently fewer people living with
disease. We term this the ‘incidence effect’.
However there is a second opposing effect, which we
will term ‘population aging’ (shown in yellow in Fig. 1).
This is an increase in the number of older people because
of reduced mortality, resulting from reduced risk of disease
or increased (disease-specific) survival. As the incidence
rate of many chronic diseases increases with age [10–12],
this will result in an increase in the absolute number of
incident cases, and therefore also in the number of people
living with disease.
A third effect may also occur, which we will term the
‘disease survival effect’. Physical activity may increase
disease-specific survival, for example it is used as a treat-
ment for some diseases (e.g. ischaemic heart disease) [13].
The average duration of disease survival will increase,
resulting in more people living with disease. It will also
contribute to population aging. Consequently, when con-
sidering these later two effects (‘population aging’ and
‘disease survival’), it is no longer clear whether and the
extent to which increases in physical activity will be
associated with reductions in the number of incident cases
or the number of people living with disease.
From an individual (or population) perspective all three
effects are a form of ‘health gain’. Respectively they result
in reduced risk of disease onset, increased life expectancy,
increased disease-specific life expectancy (and likely an
associated reduction in disease severity). However, our
interest is in exploring their cumulative effect, at the
population-level, on need for health and social care,
specifically incident cases and people living with disease.
Summary of existing research
Whilst we think the question is intrinsic to modern public
health practice, particularly in the UK where there is an
expectation that preventive health services should reduce
pressure on health and social care [4, 7, 9], surprisingly
little research has explored these issues. There is an
existing literature concerned with disease expansion and
compression, respectively referring to an increase and a
decrease in the mean duration an individual person lives
with disease [13–15]. The focus of this literature is
understanding how health and life expectancy have
evolved in past, or may evolve in the future [13, 14, 16],
rather than understanding the effect of changes in indi-
vidual risk factors on the number of individuals with
disease.
A few observational studies have tested the association
between physical activity and healthcare utilisation, but such
studies, particularly when cross-sectional, do not adequately
account for disease being postponed until after the period of
observation [15, 17–20]. Studies that make use of
lifetable modelling (and which use data from observational
studies) can address this limitation, but have generally
described the effects at the individual rather than the popu-
lation level [19–24]. These studies have tended to focus on
single diseases, often cardiovascular disease, [19, 20, 22] so
may not adequately consider how one disease may affect
another disease (e.g. changes in dementia incidence may be
brought about by reduced incidence of and increased sur-
vival from cardiovascular disease). They report only one
measure of healthcare need, average years lived with disease
or disability. This measure does not consider how many
people develop disease (i.e. do a few people live with disease
for a long time, or many people for a short time), which may
have implications for healthcare resources.
Fig. 1 How increases in
physical activity may affect the
number of incident cases of and
people living with
cardiovascular disease
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Understanding the effect of increases in physical activity
on the indices of disease burden is also important for health
impact modelling, an increasingly important tool that seeks
to estimate the health benefit from preventive interventions
[25]. Whilst some modelling methods (e.g. micro-simulation
and multi-state life table) can make allowance for changes in
life expectancy, such techniques are often not employed
when undertaking physical activity health impact modelling
[26–28] or estimating the burden of disease attributable to
insufficient physical activity [29, 30].
Study aims
The aim of this paper is to contribute to a richer under-
standing of how physical activity may affect disease in a
population as it relates to need for health and social care
(incident cases and people living with disease), making
allowance for changes in longevity. While our focus is
physical activity many of the principles that the paper
outlines will apply to other risk factors. We are primarily
interested in diseases for which regular physical activity is
protective and do not consider in detail diseases whose
incidence is independent of physical activity (e.g. some
cancers) but whose incidence rises with age.
Methods
Model description
We developed a hybrid micro-simulation life table model
(Fig. 2) to describe the effects of changes in physical
activity within the English adult population on survival and
indices of need. This used two modelling processes: (1)
micro-simulation that described the effect of changes in
physical activity on disease risk at the individual level,
from which population impact fractions for disease inci-
dence and disease case fatality were derived; and (2) a
proportional life table model that described the effect of
changes in incidence and case fatality on prevalence and
survival for each disease. From this estimates of changes in
the indices of need were made. Further information is
given in the methods supplement.
1. The micro-simulation model
We simulated a population of 8118 adults, represen-
tative of the English adult (aged 16 years and over)
population in terms of age, sex and physical activity
level. Each individual’s physical activity level could
change independently and was related to their disease
risk. Physical activity level was measured in marginal
MET-hours, a product of the intensity and duration of
physical activity [27, 31]. Given the evidence of a non-
linear relationship between physical activity and disease
risk, and following the approach used by others, we
assumed that disease risk was log linearly associated
with a power transformation of the physical activity
exposure [31].
Changes in physical activity and consequent change in
disease risk for an individual were modelled by shift
along the physical activity disease curve. Potential
impact fractions, a measure of change in average disease
risk, were estimated by a weighted sum of the ratio of
Fig. 2 Schematic outline of the model. PIF = potential impact fraction
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the relative risk observed under different scenarios of
increases in physical activity compared to baseline (i.e.
physical activity levels are unchanged). This is a stan-
dard measure, which is similar to a population
attributable fraction, and is used to estimate the change
in health status of a population due to a change in the
distribution of a risk factor within a population [32, 33].
Allowance was made for a delay between physical
activity and its effect on disease risk.
2. Proportional multistate life table model
We used a proportional multi-state life table model,
consisting of two parts: a general life table model, and a set
of disease life tables [34]. This approach has been adopted
by others to model the effect of physical activity [22, 35],
or other risk factors, on health [21, 36].
Briefly, the general life table consisted of two states
(alive and dead) and described the probability of dying at
any given age in the subsequent year. The general life
table was used to describe survival of a cohort from birth to
death, and estimated the number of people alive. Each
disease life table only tracked events related to a single
disease, and consisted of three states (alive without disease,
alive with disease, dead). Transition hazards (incidence and
case fatality) were used to estimate the probability of
moving between states in any given year of life. We
assumed no disease remission. The disease life tables were
used to estimate disease prevalence and disease-specific
mortality by age and sex.
Under each scenario a new set of transition hazards
(incidence and case fatality) for each disease was calcu-
lated by multiplying the baseline transition hazards by
potential impact fraction. This in turn led to a new estimate
of disease-specific mortality. Changes in each disease-
specific mortality fed into the general life table altering the
probability of dying, thus allowing us to model changes in
survival (population aging) that results from changes in
disease incidence and disease-specific survival for the six
diseases.
Diseases
We included diseases if: (a) they were important causes of
morbidity or mortality; (b) there was wide consensus that
physical activity reduced incidence of that disease; and
(c) estimates of the effect of physical activity on incidence
of that disease could be extracted from published meta-
analyses. Diseases included were ischaemic heart disease,
stroke, type 2 diabetes, dementia, colon cancer and breast
cancer [3, 30, 46]. We assumed that physical activity
affected the incidence of all six diseases and that it affected
survival (case fatality) of three diseases (ischaemic heart
disease, colon cancer and breast cancer).
Outcomes
We chose two primary indices of need that may reflect
healthcare utilisation: number of people living with disease
and number of incident cases [37, 38]. To ensure we
measured disease that was postponed until later life, we
followed a cohort (n = 100,000) from birth to death (or
100 years of age). Measuring these indices across the life
of the cohort gave two outcomes: person-years lived with
disease, and total incident cases. We prefer the term ‘need’
in preference to ‘burden’ which is less precise and may also
encompass years of life loss [30, 39].
We estimated the person-years lived with disease by
summing the product of the age-specific prevalence (taken
from the disease life table) and the number of people alive
at each age (taken from the general lifetable). We estimated
total incident cases by summing the product of the age-
specific disease incidence (taken from the disease life
table) and the number of people alive at that age. We then
estimated percentage change under the scenario being
studied (relative to baseline) for these two outcomes.
The former outcome may be an important indicator of
need for healthcare [37, 38, 40] where significant resources
are required throughout the course of the disease (e.g. type
2 diabetes or dementia). The latter may be an important
indicator of need where significant resources are required
around the time of diagnosis (e.g. cancer).
To compare our estimates with measures that do not
make allowance for increasing life expectancy, we used
comparative risk assessment (CRA) methods to estimate
the change in person-years with disease, by summing the
product of age-specific prevalence (at baseline), the num-
ber of people alive (at baseline) and the potential impact
fraction [41, 42]. We estimated the percentage change
relative to baseline. We term this metric ‘person-years with
disease (unchanged life expectancy)’.
The estimates of potential impact fraction used in the
lifetable model and when using comparative risk assessment
methods were the same. The observed differences between
the two methods thus reflected the different way that these
two methods simulated changes in survival and the pathways
they explicitly modelled. Comparative risk assessment
models consider only the incidence effect, whereas propor-
tional multistate lifetable additionally consider the popula-
tion aging effect and the disease survival effect (Fig. 1).
We also estimated the change in life expectancy for each
scenario using the general life table.
Scenarios
We explored two scenarios. First, ‘meeting guidelines’, in
which all adults met the UK adult physical activity
guidelines (150 min of moderate-to-vigorous physical
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activity (MVPA) per week) [43]. We assumed this was
achieved by walking for 150 min on flat ground at 3 mph,
which is likely to be the most feasible way for the popu-
lation to meet this goal. This is equivalent to 5.75 marginal
MET-hours per week [44]. Those individuals who were
already undertaking at least this amount did not change
their physical activity level, all other individuals increased
their physical activity level to 5.75 marginal MET-hours.
Second, ‘Shift’, in which we assumed that all adults,
irrespective of their current physical activity level,
increased their physical activity by 5.75 marginal MET-
hours. We also modelled the effect of a shift of half (2.875
marginal MET-hours, equivalent to 75 min walking or
similar MVPA per week) and 50% more (8.625 marginal
MET-hours, equivalent to 225 min of walking or other
MVPA per week) than this.
Each scenario is compared to baseline, i.e. no increase in
physical activity above current physical activity levels.
Data
We used the following sets of data: data on physical
activity; data describing the relationship between physical
activity and disease; estimates of transition hazards (inci-
dence and case fatality) for the disease life tables; and
estimates of mortality for the general life table. We sought
data that were representative of the English population.
Estimates of physical activity level by age and sex were
derived from the Health Survey for England 2012, which
incorporated the International Physical Activity Question-
naire (IPAQ) [45]. Physical activity level was estimated by
summing the product of weekly duration of activity (in hours)
and the intensity of activity (measured in marginal MET) for
each activity reported. Estimates of intensity were taken from
Ainsworth’s Compendium of physical activity [44].
Estimates of the association between physical activity
and the outcome of interest were taken from meta-analyses
of observational studies or randomised controlled trials
[46–55]. We used adjusted estimates of relative risk to
describe the un-confounded association between physical
activity and disease risk.
Estimates of transition hazards (incidence and case
fatality) were made using DISMOD II v1.05 (World Health
Organisation, 2001–2009) [56], based on routine data or
other large studies in the UK [11, 12, 57–61].
We used the interim lifetable for England for the years
2010-2012 [62] to parameterise the general lifetable of our
model.
Uncertainty and sensitivity analyses
We estimated 95% uncertainty intervals (2.5th to the 97.5th
percentile) from 5000 iterations of a Monte Carlo analysis.
For each iteration a random value was drawn from the
described distribution for each parameter. We modelled
uncertainty for three sets of parameters: the power trans-
formation describing the relationship between physical
activity and risk; the association of physical activity with
relative risk of disease incidence; the association of phys-
ical activity with relative risk of case fatality.
We also undertook sensitivity analyses to examine the
effect of changes to the model structure or parameters on
the primary outcomes. Parametric uncertainty was tested
by constructing tornado plots for the two primary outcomes
and for change in life expectancy for each of the six
diseases.
We examined structural uncertainty by making changes
to the model structure (omitting, adding or changing parts
of the model). We tested the following changes. First we
assumed that physical activity did not affect cancer sur-
vival, to reflect uncertainty about whether physical activity
has a causal role in cancer survival. The association
between physical activity and survival after incident colon
or breast cancer is reported in observational studies [47, 55]
and could be due to confounding by indication (i.e. that
people who are able to be physically active are healthier
because they have a less aggressive cancer) [55, 63].
Second we assumed that physical activity reduced the
incidence of other cancers (lung, prostate and pancreatic).
Whilst not incorporated into some physical activity
guidelines [1, 3, 43], associations between physical activity
and reduced incidence of these cancers has been consis-
tently observed [64], and our initial work suggested that
our model might be under-estimating the effect of physical
activity on all-cause mortality. Third we assumed that there
was no lag between physical activity and its effect on
disease risk. There is an absence of evidence about the
length of lags, and we wanted to understand the effect that
modelling lags was having on the overall picture. Fourth
we assumed that only walking, sport and recreational
physical activity contribute to physical activity levels. This
reflects current epidemiological studies of physical activity
and disease, which predominantly considers either leisure
time physical activity or walking, and thus excluded
domestic, transport and occupation activity.
Results
Under the ‘meeting guidelines’ scenario estimated life
expectancy (at birth) increased by 95 days (95% uncer-
tainty intervals: 68–126 days), or 89 days for men
(60–123 days) and 101 days for women (75–131 days).
Changes in person-years with disease and total incident
cases for this scenario are shown in Fig. 3. Person-years
lived with disease decreased for ischaemic heart disease,
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stroke, type 2 diabetes and dementia, and increased for
colon cancer (uncertainty intervals not including zero) and
breast cancer (uncertainty intervals including zero). The
decreases observed for ischaemic heart disease and
dementia were small (with uncertainty intervals that
included zero). Total incident cases decreased for all six
diseases, although the 95% uncertainty intervals included
zero for dementia and colon cancer.
Estimates of the decrease in person-years lived with
disease were considerably smaller than estimates made
using comparative risk assessment methods (Fig. 3). The
differences were particularly marked for IHD, dementia,
colon cancer and breast cancer.
Estimates of the change in mean age of onset (amongst
those who develop disease) are shown in Table 1. For
dementia, colon cancer and breast cancer the mean age of
onset increased (i.e. was later). For IHD, stroke and type 2
diabetes the mean age of onset decreased.
Results for the shift scenarios (increases in physical
activity of either 75, 150 or 225 min) showed a similar
pattern, although the absolute changes were different
(Fig. 4). The one noticeable difference between the ‘shift’
and ‘meeting guidelines’ scenarios was that the estimated
change in person-years lived with breast cancer changed
from being a small decrease (under the ‘shift’ scenario) to a
small increase (under the ‘meeting guidelines’ scenarios),
although for both scenarios the uncertainty interval inclu-
ded zero.
Graphs of survival, disease incidence and number alive
with disease by age are shown for the scenario with the
greatest effect (‘shift’ of 225 min) in order to highlight the
pattern of change (Figs. 5, 6, 7). These show that an
increase in physical activity is associated with a decrease in
the incidence of each disease (Fig. 5) and a rightwards shift
of the survival curve (Fig. 6). The number of people living
with disease by age is shown in Fig. 7. For some diseases
(e.g. stroke and type 2 diabetes) the curve representing
increased physical activity is flatter, for other diseases there
is a rightward shift in the curve (e.g. breast cancer) or a
combination of a rightward shift and flattening (e.g.
ischaemic heart disease and dementia). For colon cancer
the curve shifts to the right and has a higher peak.
Sensitivity analyses
Tornado plots showing the effect of parametric uncertainty
on change in person years with disease, incident cases and
life expectancy are shown in the supplementary results
(Figures A2–A4). Of note, changes in the values of three
parameters (association between physical activity and
Fig. 3 Effect of meeting physical activity guidelines on the change in
indices of need. IHD ischaemic heart disease, LE life expectancy;
person-years with diseases (unchanged LE) assumes that LE (life
expectancy) is held constant at the baseline value—these estimates
were made using comparative risk assessment methods
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dementia, power transformation describing relationship
between physical activity and risk, association between
physical activity and ischaemic heart disease fatality)
within the reported range of uncertainty, altered the esti-
mate of change in person-years lived with dementia and of
the change in total incident cases from a decrease to an
increase. Similarly a stronger association of physical
activity with relative risk of colon cancer incidence, altered
the estimate of change in incident cases from a decrease to
an increase.
The effect of different structural configurations of
model, compared to the standard model, on the reported
outcomes is shown in Table 2. Broadly under each analysis
the overall pattern of results comparing the three different
estimates of need is similar. There were relatively large
differences in the estimate of change in person-years lived
with disease using the lifetable method (that allowed life
expectancy to change) compared with comparative risk
assessment method (that assumed life expectancy was
unchanged). Assuming that physical activity did not affect
colon cancer survival attenuated the estimated increase in
person-years lived with colon cancer, such that uncertainty
intervals included zero, and for breast cancer the point
estimate changed from a small increase to a small decrease
(uncertainty intervals including zero).
Discussion
Summary of main findings
Increases in physical activity were associated with a
reduction in disease incidence and an increase in life
expectancy. Generally, increases in physical activity were
associated with a reduction in measures of need for
healthcare (both incident cases and person-years lived with
disease) over the life of the cohort. However, estimates of
the effect of physical activity on indices of need, using a
lifetable method that made allowance for change in sur-
vival, were more conservative than similar estimates made
using comparative risk assessment methods (e.g. dementia,
ischaemic heart disease) that did not make allowance for
changes in survival. For some diseases, for which physical
activity is protective, increases in physical activity might
be associated with an increase in the person-years lived
with disease (e.g. colon cancer).
Strengths and limitations
The strengths of this study include: the explicit modelling
of aging, modelling the effect of physical activity on
mortality through a set of diseases, considering indices of
healthcare need, long period of follow-up, and making
allowance for a lag between physical activity and its effect
on disease risk. We have also drawn comparisons between
modelling techniques (lifetable vs. comparative risk
assessment) to demonstrate the additional impact of mod-
elling increased survival on the reported outcomes.
As with all modelling work a number of assumptions
have been made. Some of the uncertainty associated with
these assumptions has been explored by uncertainty and
sensitivity analyses. While parametric and structural
uncertainty affected the magnitude of the results, it did not
affect the pattern of results comparing the different mea-
sures of need.
We have focused on the diseases for which physical
activity is protective. The effect of increases in physical
activity (and resultant increases in life expectancy) on other
diseases whose incidence is age-dependent and indepen-
dent of physical activity (e.g. some cancers) will be dif-
ferent. For such diseases increases in physical activity are
likely to be associated with an increase in the both the
number of incident cases and the person-years lived with
disease (see pancreatic, lung and prostate cancers in
Table 2 under the ‘standard model’).
Table 1 Change in mean age
of disease onset and percentage
of cases prevented for the
‘meeting guidelines’ scenario
Change in mean age of onset (days) Percentage of cases prevented (%)
IHD -6.9 (-39.9 to 27.3) 4.6 (2.4 to 7.6)
Stroke 15.2 (-40.5 to 75.2) 4.6 (2.1 to 7.9)
Type 2 diabetes 239.8 (269.1 to 214.1) 2.5 (1.1 to 4.4)
Dementia 133 (97.4 to 173) 0.4 (-1.9 to 3.6)
Breast cancer 73.6 (27.9 to 115) 0.8 (0.0 to 2.0)
Colon cancer 52.9 (18.5 to 88.9) 0.6 (-0.8 to 2.5)
Meeting guidelines scenario assumes that all adults who are not presently doing 5.75 marginal MET-hours
of physical activity (equivalent to 150 min of walking per week) increase their physical activity to 5.75
marginal MET-hours, the physical activity level of adults who are doing more than 5.75 marginal MET-
hours per week is unchanged; LE life expectancy, IHD ischaemic heart disease; bold type indicates that the
uncertainty intervals do not overlap with zero
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We have modelled cancer as a chronic disease without
recovery or remission. While this may not reflect the
course of some cancers (i.e. remission or cure), it does
reflect the convention of measuring cancer prevalence and
the increasing recognition that cancer can be a chronic
disease [65, 66]. We have considered only some measures
of need for healthcare and have not considered severity, co-
morbid illness, or costs, which could give a fuller picture of
the impact on health and social care. It seems likely for
some diseases (e.g. ischaemic heart disease, type 2 dia-
betes) that increases in physical activity will be associated
with reductions in disease severity or improvements in
quality of life [54, 67, 68], which the outcome measures do
not reflect. This may be an important ‘health gain’, which
we have not explicitly considered and is likely to have
implications for healthcare utilisation.
Fig. 4 Estimate of the effect of
a ‘shift’ in physical activity
levels on changes in indices of
need. IHD ischaemic heart
disease; LE life expectancy;
person-years with diseases
(unchanged LE) assumes that
LE (life expectancy) is held
constant at the baseline value—
these estimates were made using
comparative risk assessment
methods; three scenarios
represent a ‘shift’ in physical
activity whereby physical
activity increases for everyone
by the specified amount
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We should be particularly cautious about the interpre-
tation of data amongst the very old (aged 80 years and
over). First, there is relatively limited data on disease
parameters (incidence and prevalence) beyond age
90 years, and while mortality data is complete to
100 years, the coding of deaths in older age may be less
reliable [69, 70]. Second, we have assumed that the effect
of physical activity on disease incidence is similar (on a
relative scale) throughout life, although its effect is much
less studied in older age. Third, the increases in physical
activity modelled in later life may be less achievable, either
because of co-morbidities or limited cardiovascular
reserve. Fourth, co-morbidities are more common in older
age, and the effect of physical activity on disease risk when
there are co-morbidities is not explicitly represented in a
proportional life-table model.
Finally, we suggest our results should not read as
forecasts as to what would happen from increases in
physical activity in the future, in England. Changes in
disease incidence or other risk factors (e.g. cardiovascular
incidence has declined and life expectancy increased in
the past 50 years) [71, 72] would affect such forecasts
and have not been considered. Rather one should see the
work as an exploration of the effect of increases in
physical activity assuming that other factors are
unchanged.
Fig. 5 Incidence of the six diseases by age comparing baseline with a
scenario of everyone doing an additional 225 min of moderate
intensity physical activity. Shift (225) represents a scenario of
everyone doing an additional 8.675 marginal MET-hours of physical
activity per week, equivalent to an additional 225 min of additional
moderate physical activity at 3.3 MET, e.g. walking at 3 mph on level
ground
Fig. 6 Number of people alive
by age from an initial cohort of
100,000 women and 100,000
men; comparing baseline with a
scenario of everyone doing an
additional 225 min of moderate
physical activity. Shift (225)
represents a scenario of
everyone doing an additional
8.675 marginal MET-hours of
physical activity per week,
equivalent to an additional
225 min of additional moderate
physical activity at 3.3 MET,
e.g. walking at 3 mph on level
ground
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Model validity: comparisons with other estimates
Comparing some outputs of our model, with other pub-
lished estimates may serve as a form of model validation.
Our estimate of the increase in life expectancy (95 days)
attributed to ‘meeting guidelines’ is less than a recent
comparable estimate (256 days) if everyone in the UK
walked briskly for at least 20 min daily [2]. It is also less
than an estimate of the increase in life expectancy from
everyone aged between 40 and 65 years of age meeting
physical activity guidelines (168 days), using a modelling
approach that shared some characteristics with ours [73].
Both of these studies modelled the effect of physical
activity on mortality directly, rather than through disease
states as we did. Other methodological differences may
explain the discrepancies (e.g. how ‘inactivity’ equates to
marginal MET-hours).
We can also draw comparisons with estimates of the
effect of physical activity on measures of need made using
comparative risk assessment methods. Generally such
estimates tend to suggest a bigger effect of physical activity
than we observed [8, 26, 27, 29]. For example modest
increases in walking and cycling were estimated to reduce
incident cases for the diseases we consider here by 5% (for
colorectal cancer) to 11.5% (for type 2 diabetes) [26].
Different model parameters and differences in the scenar-
ios may explain the differences.
Taken together these findings may suggest that our
model is under estimating the effect of physical activity on
disease, relative to other models. However our conclusions
primarily relate to the pattern of results, which the
sensitivity analyses suggest are largely unaffected by
changing the dose of (and thus the effective efficacy of)
physical activity, rather than absolute estimates.
Effect of physical activity on need: comparison
with other work
Limited other work has explored the effect of changes in
physical activity on specific diseases. Past work has also
tended to frame findings around average changes for an
individual (e.g. disease expansion and compression)
[20, 22], although such measures can be compared to our
measure of person-years with disease (See supplementary
material).
Previous work has reported that increases in physical
activity from none or low levels to moderate or high levels
were associated with a reduction in the average number of
years lived with disability [19]. Whilst we have not esti-
mated all-cause morbidity we note that the general trend
was for the person-years lived with disease to decrease.
Two modelling studies reported that increases in phys-
ical activity (during mid-life) were associated with small
non-significant increases in average years lived with car-
diovascular disease [19, 20], and a third reported a sig-
nificant decrease in average years lived with dementia [74].
While the central estimates are discordant (we found small
non-significant decrease for ischaemic heart disease and
dementia), the uncertainty intervals overlap.
Lifetable modelling has also been used to describe the
effect of other risk factors on years lived with cardiovas-
cular disease [21–23]. Smoking cessation was associated
Fig. 7 Number of people living with six different diseases by age
from an initial cohort of 100,000 women and 100,000 men;
comparing baseline with a scenario of everyone doing an additional
225 min of moderate physical activity. Shift (225) represents a
scenario of everyone doing an additional 8.675 marginal MET-hours
of physical activity per week, equivalent to an additional 225 min of
additional moderate physical activity at 3.3 MET, e.g. walking at 3
mph on level ground
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Table 2 Summary of model outcomes for different ‘structural’ configurations of the model for the ‘meeting guidelines’ scenario
Standard model ‘Structural’ change to the standard model
PA has no effect on




No lag between physical





Increase in LE (days)
Women 101 (75–131) 85 (60–115) 106 (79–138) 126 (92–170) 128 (95–164)
Men 89 (61–123) 82 (54–117) 95 (67–130) 103 (72–141) 115 (82–154)
All 95 (69–126) 84 (58–115) 101 (74–133) 115 (83–153) 115 (83–153)
Change in total incidence cases (%)
IHD 24.6 (27.6 to 22.4) 24.7 (27.7 to 22.5) 24.5 (27.6 to 22.3) 24.8 (28.0 to 22.4) 26.0 (29.3 to 23.2)
Stroke 24.6 (27.9 to 22.1) 24.7 (28.1 to 22.2) 24.5 (27.8 to 21.9) 24.8 (28.3 to 22.0) 26.0 (29.7 to 22.8)
Type 2
diabetes
22.5 (24.4 to 21.1) 22.6 (24.4 to 21.1) 22.5 (24.3 to 21.1) 22.8 (24.7 to 21.2) 24.0 (26.6 to 21.9)
Dementia -0.4 (-3.6 to 1.9) -0.7 (-3.9 to 1.6) -0.2 (-3.4 to 2.1) -2.2 (-7.2 to 1.2) -0.8 (-4.9 to 2.0)
Breast
cancer
-0.8 (-2.0 to 0.0) -0.8 (-2.1 to 0.0) -0.7 (-2.0 to 0.1) 21.6 (23.3 to 20.3) 21.6 (23.3 to 20.3)
Colon
cancer
-0.6 (-2.5 to 0.8) -0.7 (-2.5 to 0.7) -0.5 (-2.4 to 0.9) -1.7 (-4.6 to 0.5) -1.3 (-4.0 to 0.7)
Lung
cancer
1.5 (1.1 to 2.0) 1.1 (0.8 to 1.5) -0.7 (-1.8 to 0.3) 1.9 (1.3 to 2.5) 1.9 (1.4 to 2.5)
Prostate
cancer
1.3 (0.9 to 1.7) 1.4 (0.9 to 1.9) 0.5 (-0.3 to 1.2) 1.5 (1.1 to 2.1) 1.6 (1.2 to 2.1)
Pancreatic
cancer
1.7 (1.2 to 2.2) 1.5 (1.0 to 2.1) -2.0 (-8.1 to 1.4) 2.1 (1.5 to 2.7) 2.1 (1.6 to 2.8)
Change in person-years with disease (%)
IHD -1.2 (-4.2 to 1.4) -1.3 (-4.5 to 1.3) -1.0 (-4.3 to 1.5) -1.1 (-4.5 to 1.6) -2.5 (-6.1 to 0.7)
Stroke 23.1 (26.0 to 21.1) 23.2 (26.1 to 21.2) 23.0 (25.9 to 21.0) 23.1 (26.3 to 21.0) 24.7 (28.1 to 22.0)
Type 2
diabetes
21.5 (23.2 to 20.2) 21.6 (23.3 to 20.3) 21.4 (23.1 to 20.1) 21.5 (23.3 to 20.1) 22.8 (25.2 to 20.8)
Dementia -0.6 (-3.7 to 1.6) -0.9 (-4.1 to 1.3) -0.4 (-3.6 to 1.8) -2.5 (-7.4 to 0.9) 21.3 (25.5 to 1.6)
Breast
cancer
0.8 (-0.50 to 1.7) -0.1 (-1.3 to 0.6) 0.8 (-0.4 to 1.8) 0.5 (-1.2 to 1.8) 0.3 (-1.5 to 1.8)
Colon
cancer
4.4 (1.1 to 10.3) 0.3 (-1.4 to 1.6) 4.6 (1.1 to 10.4) 4.1 (-0.1 to 10.2) 4.9 (0.4 to 11.4)
Lung
cancer
1.8 (1.3 to 2.4) 1.6 (1.1 to 2.2) -0.3 (-1.4 to 0.7) 2.2 (1.5 to 3.0) 2.3 (1.7 to 3.0)
Prostate
cancer
1.9 (1.3 to 2.6) 1.7 (1.2 to 2.5) 1.3 (0.5 to 2.2) 2.2 (1.6 to 2.9) 2.4 (1.7 to 3.2)
Pancreatic
cancer
1.5 (1.1 to 2.0) 1.4 (0.9 to 1.9) -1.9 (-7.7 to 1.3) 1.8 (1.3 to 2.4) 1.9 (1.4 to 2.5)
Change in person-years with disease (life expectancy unchanged) (%)
IHD 25.1 (28.2 to 22.9) 25.1 (28.2 to 22.9) 25.1 (28.2 to 22.9) 25.1 (28.2 to 22.9) 26.8 (210.4 to 24.0)
Stroke 25.2 (28.3 to 22.9) 25.2 (28.3 to 22.9) 25.2 (28.3 to 22.9) 25.2 (28.3 to 22.9) 26.9 (210.4 to 24.0)
Type 2
diabetes
23.8 (26.1 to 21.8) 23.8 (26.1 to 21.8) 23.8 (26.1 to 21.8) 23.8 (26.1 to 21.8) 25.1 (28.0 to 22.5)
Dementia 24.0 (27.5 to 21.6) 24.0 (27.5 to 21.6) 24.0 (27.5 to 21.6) 24.0 (27.5 to 21.6) 25.3 (29.9 to 22.2)
Breast
cancer
22.4 (24.0 to 21.2) 22.4 (24.0 to 21.2) 22.4 (24.0 to 21.2) 22.4 (24.0 to 21.2) 23.2 (25.2 to 21.7)
Colon
cancer
22.2 (24.2 to 20.8) 22.2 (24.2 to 20.8) 22.2 (24.2 to 20.8) 22.2 (24.2 to 20.8) 23.1 (25.7 to 21.1)
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with an increase in the average number of years lived with
cardiovascular disease (equivalent to an increase in the
person-years lived with disease) [22]. In contrast reduc-
tions in body weight were associated with a reduction in
the average number of years lived with cardiovascular
disease [22, 23]. These findings are consistent with our
general observation that an ‘improvement’ in a risk factor
can be associated with either an increase or a decrease in
person-years lived with disease, which may not be readily
predicted from measures of relative risk alone.
We are not aware of any studies directly comparing
lifetable methods with comparative risk assessment meth-
ods, nor any studies comparing health impact modelling
that makes allowance for changes in life expectancy with
methods that do not.
Interpretation
The effect of physical activity on the healthcare need
relates to disease epidemiology and the three effects we
outlined in the introduction (see Fig. 1). The effect varies
for different diseases.
Type 2 diabetes and stroke show a similar pattern (de-
crease in incident cases, decrease in person-years lived
with disease, and both these estimates are not too discor-
dant from estimates made using comparative risk assess-
ment methods). For these diseases the incidence effect is
dominant. This reflects a relatively strong effect of physical
activity on relative risk of incidence and the absence of a
disease survival effect (i.e. physical activity does not affect
disease case fatality). For type 2 diabetes, the fall in inci-
dence rate with age also suggests that population aging is
less important.
Dementia is different (small decreases in incident cases
and person-years lived with disease that are close to zero
and much less than estimates made using comparative risk
assessment methods). The incidence of dementia increases
sharply with age, such that the population aging effect is
important. While a few cases of dementia were prevented,
more commonly the onset of dementia was postponed.
Ischaemic heart is different again (large decrease in
incident cases but relatively small decrease in person-years
lived with disease). The disease survival effect is impor-
tant, whilst cases of disease are prevented those with dis-
ease are living longer.
For colon and breast cancer the disease survival effect is
also important. In addition few cases of colon and breast
cancer are prevented, which may be attributed to popula-
tion aging and a rise incidence with age and/or a relatively
weak effect of physical activity on incidence. For colon
cancer the combination of these effects meant that
increases in physical activity were associated with a rela-
tively large increase in person-years with colon cancer. The
large magnitude of the increase is, in large part,
attributable to a strong effect of physical activity on sur-
vival after diagnosis (see Table 2). However given that this
estimate is based only on observational studies, which may
be subject to confounding by indication (see Uncertainty
and Sensitivity Analyses in the Methods), the large
increase in person-years lived with colon cancer should be
interpreted cautiously. Moreover, given that, within the
model, survival with breast or colon cancer would include
many people without ongoing symptoms, the clinical
importance of an increase in person-years lived with breast
or colon cancer for the health service (and individuals) is
likely to be less than for other diseases (e.g. dementia).
For some diseases, increases in physical activity were
associated with decreases in the mean age of onset. Whilst
this may appear counter-intuitive, particularly given that
the rightward shift of the disease curve (Fig. 6) suggesting
Table 2 continued
Standard model ‘Structural’ change to the standard model
PA has no effect on




No lag between physical







0 (0 to 0) 0 (0 to 0) -2.5 (-3.7 to -1.6) 0 (0 to 0) 0 (0 to 0)
Prostate
cancer
0 (0 to 0) 0 (0 to 0) -1.0 (-0.4 to -2.0) 0 (0 to 0) 0 (0 to 0)
Pancreatic
cancer
0 (0 to 0) 0 (0 to 0) -3.9 (-0.5 to -10.0) 0 (0 to 0) 0 (0 to 0)
Meeting guidelines scenario assumes that all adults who are not presently doing 5.75 marginal MET-hours of physical activity (equivalent to
150 min of walking per week) increase their physical activity to 5.75 marginal MET-hours, the physical activity level of adults who are doing
more than 5.75 marginal MET-hours per week is unchanged; IHD ischaemic heart disease; bold type indicates that the uncertainty intervals do
not include zero; Outcomes for lung cancer, prostate cancer and pancreatic cancer are included under all variants of the model for comparison.
Physical activity only affects the incidence of lung cancer, prostate cancer or pancreatic cancer in the third model described as ‘PA effects
incidence of other cancers’. In all other models physical activity does not affect the incidence of lung cancer, prostate cancer or pancreatic cancer
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later onset, one should remember that the estimates reflect
the mean age for those who develop disease. Thus, it is
possible for the mean age of onset to increase, whilst the
age of onset of those who develop disease is delayed if
cases of disease are prevented predominantly in those who
would have developed the disease at old age.
Implications
Broadly our work suggests that changes in life expectancy
are important when evaluating or formally estimating the
effect of physical activity on indices of need for healthcare.
Whilst we have only considered physical activity, in the
context of a single setting (England), we think our broad
conclusion, concerning the importance of considering
changes in life expectancy, is likely to extend to other risk
factors and other settings. An increase in disease incidence
with age and the three different effects are common to
other risk factors and diseases. Whilst the nature and
strength of the association between other risk factors and
diseases may differ, other important risk factors for non-
communicable diseases (e.g. smoking, alcohol and diet) are
all associated with both mortality and disease incidence.
The work has two important implications. First it sug-
gests that public health officials and policy makers should
be more cautious about claiming that interventions
designed to reduce risk will lead to large reductions in need
for healthcare, with consequent reductions in utilisation of
healthcare. Whilst such resource-based arguments may be a
popular way to frame arguments [7, 9] and may sometimes
be appropriate, they should be tempered with realism.
Instead it may be more appropriate to frame arguments
around improvements in health.
Similarly it is common to talk of ‘‘prevention’’, but our
results suggest that risk reduction may result in little or no
prevention of some diseases. The term ‘‘prevent’’ may be
sometimes be appropriate (e.g. the effect of physical
activity on diabetes), but sometimes ‘‘delay’’ may be most
appropriate (e.g. the effect of physical activity on demen-
tia). A sensible phrase may be ‘‘risk reduction which may
delay or prevent disease onset’’, reflecting the language in
some recent publications [75, 76].
The second important implication concerns public
health modelling. Researchers who undertake such mod-
elling should consider using lifetable models or other tools
to make allowance for increased life expectancy and the
delay in onset of the disease. Much of the work that con-
siders the benefits of physical activity (or costs of physical
inactivity) and other behaviours uses comparative risk
assessment modelling [8, 26, 29, 77].
Our paper also suggests grounds for caution when
making another common assumption that an aging popu-
lation leads to increased need for health and social care
[13, 78]. For example there have been forecasts that pop-
ulation aging will lead to a significant rise in need for
dementia care [79, 80]. Our work suggests that if changes
occur in a risk factor, which is a risk factor for both mor-
tality and for disease incidence, then it is possible for the
population to age whilst the need for healthcare (at least for
some diseases) is relatively unchanged. We note that recent
research suggests that the number of people living with
dementia is largely unchanged in the last 10–20 years,
despite population aging [11, 81].
Finally, despite a note of caution about implications for
healthcare utilisation, our work does underscores the ben-
efits of physical activity for health (e.g. increased life
expectancy and prevention of cases or delay in disease
onset). For most diseases, even making allowance for
changes in life expectancy, measures of need tend to
decreases.
Future research
This work only partially answers the question about the
extent to which increases in physical activity, when con-
sidering its effect on survival, affect the actual need for
healthcare. Future work could explore the effect on all-
cause disability, considering disease severity and other
diseases (including those whose incidence increases with
age but is independent of physical activity). It would also
be informative to describe the impact on a population of
mixed ages (rather than a birth cohort) over a time horizon
that is more prescient for decision makers (e.g.
5–20 years), and to explore the impact on changes in
physical activity restricted to particular phases of life (e.g.
mid-life). To understand the economic implications a full
economic appraisal would be required. This could consider
other factors (e.g. deferment of cost if disease is delayed)
and other sources of economic costs or benefits (e.g. tax
base from an increased population, productivity of a
working age population that is healthier, increased pension
costs from an older population).
Further work should also seek to understand the limits of
life-table models, and the extent to which violations of the
underlying assumptions around disease independence
affect the model outcomes. It would also be of value to
repeat this work with other risk factors, notably smoking
which has a pronounced effect on mortality [82].
Conclusions
Our work reaffirms the benefits of physical activity for
health (increased life expectancy and prevention of or
delay in disease occurrence). For most diseases for which
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physical activity is protective, increases in physical activity
are associated with decreases in healthcare need. However
incident cases of disease may be delayed or the period of
time lived with disease may increase, such that the
decreases in need may be relatively small and less than is
sometimes expected.
We suggest some areas of public health practice should
be more cognisant of the effect of increased survival on
indices of need for healthcare. Public health officials
should consider exercising greater caution when making
claims about whether and the extent to which increases in
physical activity or improvement in other risk factors will
reduce need for health or social care. Instead the benefits of
risk reduction interventions may be better described in
terms of improved health (preventing or delaying disability
and delaying death). Public health modellers should con-
sider the potential impact of changes in longevity when
designing health impact models.
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